Stewart Abbot, Chief Scientific Officer, Adicet Bio

Stewart Abbot | Chief Scientific Officer | Adicet Bio » speaking at Advanced Therapies

Elsa Abranches, Group Leader, Section Of Stem Cell Biology, NIBSC/MHRA

Prasad Adusumilli, Deputy Chief, Thoracic Surgery, Vice Chair, Department Of Surgery, Memorial Sloan-Kettering Cancer Center

Nada Alaaeddine, Head Of The Regenerative And Inflammation Lab In The Faculty Of Medicine, Lebanese university

Nada Alaaeddine | Head Of The Regenerative And Inflammation Lab In The Faculty Of Medicine | Lebanese university » speaking at Advanced Therapies

Aglaia Athanassiadou, Professor Emeritus, University of Patras

Frank Barry, Scientific Director, Regenerative Medicine Institute

Frank Barry | Scientific Director | Regenerative Medicine Institute » speaking at Advanced Therapies

Dr Roy Baynes, Senior Vice President And Head Global Clinical Development, Chief Medical Officer, Merck Sharp and Dohme (MSD)

Tim Bertram, Chief Executive Officer, ProKidney

Tim Bertram | Chief Executive Officer | ProKidney » speaking at Advanced Therapies

Luc Boileau, Chief Executive Officer, INESSS

Luc Boileau | Chief Executive Officer | INESSS » speaking at Advanced Therapies

Daria Bou Dargham, Business development manager, Genethon

Philip J. Brooks, Program Director, Office of Rare Diseases Research, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health

Alex Butcher, Consultant, Next Phase Recruitment

Paul Butler, Sales Business Development Manager, Advanced Instruments

Didier Caizergues, Head of International Regulatory Affairs, Genethon

Didier Caizergues | Head of International Regulatory Affairs | Genethon » speaking at Advanced Therapies

Heather Callahan, Director of Licensing, University of Colorado

Bradley Campbell, Chief Business Officer, Amicus Therapeutics Inc

Manuel Carrondo, Professor, iBET: Instituto de Biologia Experimental e Tecnológica

Paul S Carter, Director, Head Vector Processing, Quell Therapeutics

Paul S Carter | Director, Head Vector Processing | Quell Therapeutics » speaking at Advanced Therapies

Frederic Chereau, Chief Executive Officer, LogicBio Therapeutics

Frederic Chereau | Chief Executive Officer | LogicBio Therapeutics » speaking at Advanced Therapies

Maria Cho, VP, Business Development, Dendreon Pharmaceuticals LLC

Angela Columbano, Head Of Business Development And Partnership, Genethon

Jean-Philippe Combal, Co-Founder And Chief Executive Officer, Vivet Therapeutics

Yemisi Corinaldi, Regulatory Strategy Leader, Spark Therapeutics UK Limited

Yemisi Corinaldi | Regulatory Strategy Leader | Spark Therapeutics UK Limited » speaking at Advanced Therapies

Vicki Coutinho, VP Regulatory Affairs, GammaDelta Therapeutics

Vicki Coutinho | VP Regulatory Affairs | GammaDelta Therapeutics » speaking at Advanced Therapies

Conrad Russell Y Cruz, Assistant Professor, Children's National Medical Center; Co-Founder, Children's National Medical Center

Derek Dashti, Founder And Chief Executive Officer, D and P Bioinnovations

Derek Dashti | Founder And Chief Executive Officer | D and P Bioinnovations » speaking at Advanced Therapies

Francesco Dazzi, Professor Of Regenerative And Hematological Medicine, King's College London

Francesco Dazzi | Professor Of Regenerative And Hematological Medicine | King's College London » speaking at Advanced Therapies

Michele de Guise, Scientific Vice-President, INESSS

Michele de Guise | Scientific Vice-President | INESSS » speaking at Advanced Therapies

Graciana Diez-Roux, Chief Scientific Officer, Telethon Institute of Genetics and Medicine

Graciana Diez-Roux | Chief Scientific Officer | Telethon Institute of Genetics and Medicine » speaking at Advanced Therapies

Dominik Egger, Research Associate, University Of Natural Resources And Life Sciences Vienna

Victoria English, Victoria English, Co-Founder And Editor, Evernow Publications

Victoria English | Victoria English, Co-Founder And Editor | Evernow Publications » speaking at Advanced Therapies

Michael Ermisch, Specialist, Department Of Pharmaceuticals, G.K.V. Spitzenverband

Michael Ermisch | Specialist, Department Of Pharmaceuticals | G.K.V. Spitzenverband » speaking at Advanced Therapies

Marco Fadda, ATMP Solutions Manager, Comecer S.p.A.

Miguel Forte, Chief Executive Officer, Bone Therapeutics

Miguel Forte | Chief Executive Officer | Bone Therapeutics » speaking at Advanced Therapies

Mike Fraser, Head of EMEA Region, Novartis Gene Therapies

Mike Fraser | Head of EMEA Region | Novartis Gene Therapies » speaking at Advanced Therapies

Bobby Gaspar, CEO, Orchard Therapeutics

Bobby Gaspar | CEO | Orchard Therapeutics » speaking at Advanced Therapies

André Gerth, Chief Executive Officer, BioPlanta GmbH

Faruque Ghanchi, Consultant Ophthalmologist, Head, Bradford Ophthalmology Research Network (Born), Specialty Lead- Ophthalmology, Bradford Teaching Hospitals N.H.S. Foundation Trust

Faruque Ghanchi | Consultant Ophthalmologist, Head, Bradford Ophthalmology Research Network (Born), Specialty Lead- Ophthalmology | Bradford Teaching Hospitals N.H.S. Foundation Trust » speaking at Advanced Therapies

Paul Gissen, Professor of Metabolic Medicine, Head of Genetics and Genomic Medicine Department, UCL Great Ormond Street Institute of Child Health

Paul Gissen | Professor of Metabolic Medicine, Head of Genetics and Genomic Medicine Department | UCL Great Ormond Street Institute of Child Health » speaking at Advanced Therapies

Janet Glassford, Senior Quality Assessor, Medicines & Healthcare Products Regulatory Agency

Janet Glassford | Senior Quality Assessor | Medicines & Healthcare Products Regulatory Agency » speaking at Advanced Therapies

Simon Goldman, Investment Director, Albion Capital

David Greenwald, Vice President Of Business Development, Deerfield Management

David Greenwald | Vice President Of Business Development | Deerfield Management » speaking at Advanced Therapies

Jennifer Harbottle, Senior Scientist, R&D, Cell and Gene Therapy, Horizon Discovery Ltd

Hansjorg Hauser, Head of Department Gene Regulation and Differentiation, Helmholtz Centre for Infection Research GmbH

Christopher R Heery, Chief Medical Officer, Precision BioSciences

Christopher R Heery | Chief Medical Officer | Precision BioSciences » speaking at Advanced Therapies

Amir Hefni, VP, Global Commercial Head, Cell & Gene, Novartis

Amir Hefni | VP, Global Commercial Head, Cell & Gene | Novartis » speaking at Advanced Therapies

Christoph Herwig, Professor Of Biochemical Engineering, Vienna University of Technology

Volker Huppert, Chief Development Officer, Glycostem Therapeutics BV

Volker Huppert | Chief Development Officer | Glycostem Therapeutics BV » speaking at Advanced Therapies

Dr Moshe Israeli, Medical Director, Rabin Medical Center

Lilian Jallow, Research Coordinator, Karolinska Institutet

Lilian Jallow | Research Coordinator | Karolinska Institutet » speaking at Advanced Therapies

Robert Jones, Vice President - Global Bioservices, Cryoport Systems

Troels Jordansen, Chief Executive Officer, Glycostem Therapeutics

Margareth Jorvid, Head of Regulatory Affairs, Ilya Pharma

Margareth Jorvid | Head of Regulatory Affairs | Ilya Pharma » speaking at Advanced Therapies

Hans S Keirstead, Chief Executive Officer, AIVITA Biomedical, Inc.

Aisha Khan, Executive Director Of Lab Operations At The Interdisciplinary Stem Cell Institute, Miller School of Medicine University of Miami

Sven Kili, CEO, Antion Biosciences

Sven Kili | CEO | Antion Biosciences » speaking at Advanced Therapies

Jarema (Jarko) Kochan, Head Of Biomarkers, Diagnostics And Assay Development, Turnstone Biologics

Sebastian Kress, Postdoctoral Scientist, Institute of Cell and Tissue Culture Technologies, BOKU

Stephen Lock, Senior Marketing and Market Development Manager, EMEAI, SCIEX

Tim Luker, Global Director, External Innovation, External Research And Development, Eli Lilly And Company

Tim Luker | Global Director, External Innovation, External Research And Development | Eli Lilly And Company » speaking at Advanced Therapies

Rachel Manley, Head Of Global Outreach, Save the Cord Foundation

Peter Marks, Director, Center For Biologics Evaluation And Research (CBER), U.S. Food and Drug Administration

David Mazzo, Chief Executive Officer, Caladrius Biosciences

Janneke Meulenberg, Managing Director, MeiraGTx Netherlands B.V.

Janneke Meulenberg | Managing Director | MeiraGTx Netherlands B.V. » speaking at Advanced Therapies

Paolo Morgese, EU Director Market Access & Member Relations, Alliance for Regenerative Medicine

Paolo Morgese | EU Director Market Access & Member Relations | Alliance for Regenerative Medicine » speaking at Advanced Therapies

David Morrow, Senior Scientific Program Manager, EATRIS

David Morrow | Senior Scientific Program Manager | EATRIS » speaking at Advanced Therapies

Mary Murphy, Principle Investigator, Remedi National University of Ireland Galway

Mary Murphy | Principle Investigator | Remedi National University of Ireland Galway » speaking at Advanced Therapies

Alexander Natz, Secretary General, European Confederation of Pharmaceutical Entrepreneurs (Belgium)

Libby Naylor, Sales Account Manager, GenScript Biotech (Netherlands) B.V.

Charis Ober, Founder And Executive Director, Save the Cord Foundation

Daniel O'Mahony, Partner, Seroba Life Sciences

Nneka Onwudiwe, Former PRO/PE Regulatory Review Officer, Food and Drug Administration (FDA)

Nneka Onwudiwe | Former PRO/PE Regulatory Review Officer | Food and Drug Administration (FDA) » speaking at Advanced Therapies

Dominic O'Regan, Business Development Consultant & Investor, New Mosaic

Sean Palecek, Director for Research, University of Wisconsin, Stem Cell and Regenerative Medicine Center

Ioannis Papantoniou, Assoc. Professor of Tissue Engineering and Biomanufacturing, Prometheus division of Skeletal Tissue Engineering, KU Leuven

Detlev Parow, Head Pharmaceutical Department, DAK-Gesundheit

Vivienne Parry, Head Of Engagement, Genomics England

Vivienne Parry | Head Of Engagement | Genomics England » speaking at Advanced Therapies

David Pauza, Chief Science Officer, American Gene Technologies International Inc.

Avery Posey, Assistant Professor, University of Pennsylvania

Dr Qasim Rafiq, Associate Professor, Bioprocessing Of Cell And Gene Therapies, University College London

Lior Raviv, Vice President ,Development & Operations, Pluristem Therapeutics

Albert Ribickas, BMT Laboratory Manager, Moffitt Cancer Center

Jessica Robinson, Project director, Terrapinn Ltd

Jessica Robinson | Project director | Terrapinn Ltd » speaking at Advanced Therapies

Kate Rochlin, VP Operations & Innovation, in8bio

Mark Sawicki, Chief Executive Officer, Cryoport Systems

Mark Sawicki | Chief Executive Officer | Cryoport Systems » speaking at Advanced Therapies

Dominic Schmidt, Partner, Syncona Investment Management Ltd

Dominic Schmidt | Partner | Syncona Investment Management Ltd » speaking at Advanced Therapies

Martina Sebastian, Sales Manager, Univercells Technologies

Martina Sebastian | Sales Manager | Univercells Technologies » speaking at Advanced Therapies

Tamir Singer, Head of Commercial Development, NHS England

Tamir Singer | Head of Commercial Development | NHS England » speaking at Advanced Therapies

Owen Smith, Investment Director, 4BIO Capital

Owen Smith | Investment Director | 4BIO Capital » speaking at Advanced Therapies

Devyn Smith, CEO, Arbor Biotechnologies

Joseph Stavas, Senior Vice President of Clinical Development, ProKidney

Kendal Studd, Scientific Application Specialist, Advanced Instruments Ltd

Mathias Svahn, Chief Executive Officer, NextCell Pharma

Mathias Svahn | Chief Executive Officer | NextCell Pharma » speaking at Advanced Therapies

Magali Taiel, Medical Chief Officer, Gensight Biologics

Marina Tarunina, Research Director, Plasticell

Stefanos Theoharis, Chief Business Officer, Bone Therapeutics

Stefanos Theoharis | Chief Business Officer | Bone Therapeutics » speaking at Advanced Therapies

Pamela Tranter, Translational Reserach Manager, University College London

Birgitte Volck, Non Executive Director, Soleno Therapeutics

Birgitte Volck | Non Executive Director | Soleno Therapeutics » speaking at Advanced Therapies

Simon Waddington, Professor of Gene Therapy, UCL

Tom Wilton, Chief Business Officer, Carisma Therapeutics

Sara Wrobel, European Product Manager - Genomics, Bio-Techne

Lumeng Ye, Senior Scientist, R&D department, GenScript

Lumeng Ye | Senior Scientist, R&D department | GenScript » speaking at Advanced Therapies

Stefano Zancan, Head Clinical Development And Operations, Fondazione Telethon

Stefano Zancan | Head Clinical Development And Operations | Fondazione Telethon » speaking at Advanced Therapies